ADMA - ADMA Biologics Inc. (ADMA) Q1 2024 Earnings Call Transcript
2024-05-09 23:11:09 ET
ADMA Biologics, Inc. (ADMA)
Q1 2024 Earnings Conference Call
May 09, 2024, 04:30 AM ET
Company Participants
Skyler Bloom - Senior Director, Business Development and Corporate Strategy
Adam Grossman - President and CEO
Brian Lenz - Executive Vice President, Chief Financial Officer and General Manager, ADMA BioCenters
Conference Call Participants
Anthony Petrone - Mizuho Group
Kristen Kluska - Cantor Fitzgerald
Gary Nachman - Raymond James
Presentation
Operator
Good afternoon, and welcome to the ADMA Biologics First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 09, 2024. At this time, all participants are in a listen-only mode. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company’s request and will be available on the company’s website approximately two hours following the end of the call.
At this time, I would like to introduce Skyler Bloom, Please go ahead.
Skyler Bloom
Welcome, everyone. And thank you for joining us this afternoon to discuss ADMA Biologics financial results for the fourth quarter and full year of 2023 and recent corporate updates. I’m joined today by Adam Grossman, President and Chief Executive Officer; and Brian Lenz, Executive Vice President, Chief Financial Officer and General Manager of ADMA BioCenters.
During today’s call, Adam will provide some introductory comments and provide us an update on corporate progress, and then Brian will provide an overview of the company’s first quarter 2024 financial results. Finally, Adam will then provide some brief summary remarks before opening up the call for your questions.
Earlier today, we issued a press release detailing the first quarter 2024 financial results and summarized certain achievements in recent corporate updates. The release is available on our website at www.admabiologics.com....
ADMA Biologics, Inc. (ADMA) Q1 2024 Earnings Call Transcript